6.1 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.969
EU - Europa 4.840
AS - Asia 1.455
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 11.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.956
IT - Italia 1.477
SE - Svezia 1.126
IE - Irlanda 759
TR - Turchia 508
CN - Cina 480
DE - Germania 421
UA - Ucraina 370
SG - Singapore 292
GB - Regno Unito 233
VN - Vietnam 150
FI - Finlandia 130
CH - Svizzera 114
RU - Federazione Russa 96
AT - Austria 45
EU - Europa 21
AL - Albania 17
BE - Belgio 17
CA - Canada 13
FR - Francia 11
NL - Olanda 10
KR - Corea 7
PK - Pakistan 5
IN - India 4
HK - Hong Kong 3
LT - Lituania 3
BG - Bulgaria 2
HU - Ungheria 2
IR - Iran 2
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
IM - Isola di Man 1
JP - Giappone 1
ME - Montenegro 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 11.286
Salva come PNG Salva come JPEG
Città #
Pisa 977
Jacksonville 864
Dublin 759
Chandler 751
Boardman 459
Izmir 404
Wilmington 365
Ann Arbor 328
Ashburn 276
Singapore 223
Düsseldorf 181
Millbury 176
Boston 169
Dong Ket 150
San Mateo 116
Mestre 108
Istanbul 103
Beijing 98
Bern 92
Woodbridge 85
Seattle 84
Dearborn 79
Bremen 76
Lawrence 71
Ogden 66
Scuola 65
Princeton 55
Milan 50
Saint Petersburg 43
Vienna 41
Guangzhou 40
San Giuliano Terme 39
Chicago 35
New York 34
Shanghai 24
Nanjing 21
Padova 21
Helsinki 18
Kunming 18
Zurich 18
Hefei 17
Santa Clara 17
Brussels 16
Washington 16
Wuhan 16
Andover 14
Jiaxing 14
Norwalk 14
Bientina 12
Los Angeles 12
Yiwu 12
Cambridge 11
Fairfield 11
Florence 10
Wuxi 9
Jinan 8
San Diego 8
Martignacco 7
Munich 7
Nanchang 7
Seoul 7
Toronto 7
Verona 7
Serra 6
Berlin 5
Centrale 5
Hangzhou 5
Jinhua 5
Nuremberg 5
Rome 5
Shaoxing 5
Auburn Hills 4
Cascina 4
Chengdu 4
Graz 4
Houston 4
Lausanne 4
Shenzhen 4
Tiantai Chengguanzhen 4
Zhengzhou 4
Brescia 3
Chantilly 3
Fuzhou 3
Genoa 3
Gorizia 3
Leawood 3
Lodi 3
Lucca 3
Quzhou 3
Rho 3
Trumbull 3
Budapest 2
Castelfranco Veneto 2
Castiglione dei Pepoli 2
Chizhou 2
Dalian 2
Faisalabad 2
Frankfurt am Main 2
Grevenbroich 2
Hanover 2
Totale 7.969
Salva come PNG Salva come JPEG
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 193
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 186
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 173
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 169
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 169
Composti particolarmente catalizzatori di poliuretani 160
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 148
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 145
Method and device for measuring position and mass 143
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 142
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 138
Bucket brigade address decoding architecture for classical and quantum random access memories 136
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 134
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 132
null 129
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 126
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 126
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 121
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 118
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 116
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 113
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 112
Method for the humanization of antibodies and humanized antibodies thereby obtained 111
Laser circolari a semiconduttore con reticoli per emissione verticale 110
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 109
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 108
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 105
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 105
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 105
Method for the humanization of antibodies and humanized antibodies thereby obtained 105
Method for the potentiation of opioid analgesics effects on pain 100
INTRACELLULAR ANTIBODIES 100
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 100
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 100
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 100
Method for the humanization of antibodies and humanized antibodies thereby obtained. 98
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 98
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 98
Intracellular selection 98
Method of identifying a consensus sequence for intracellular antibodies 98
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 97
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 97
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 97
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 94
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 94
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 94
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 94
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 94
Method for the humanization of antibodies and humanized antibodies thereby obtained 93
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 93
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 93
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 93
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 92
Method for the potentiation of opioid analgesics effects on pain 92
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 92
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 91
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 91
Intracellular selection 91
Humanized anti-NGF antibodies 91
Non-human transgenic animals for the study of neurodegenerative syndromes 90
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 90
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 90
Method for the humanization of antibodies and humanized antibodies thereby obtained. 90
Intracellular selection 90
Selection of intracellular immunoglobulins 90
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 90
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 89
Humanized anti-NGF antibodies 89
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 89
Humanized anti-NGF antibodies 88
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 88
Method for the humanization of antibodies and humanized antibodies thereby obtained. 88
INTRACELLULAR ANTIBODIES 88
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 87
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 86
Novel analgesic treatment with prolonged effect 86
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 86
Selection of intracellular immunoglobulins 86
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 86
Selection of intracellular immunoglobulins 85
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 85
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 85
Novel analgesic treatment with prolonged effect 85
Method for the humanization of antibodies and humanized antibodies thereby obtained. 85
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 85
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 85
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 84
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 84
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 84
Selection of intracellular immunoglobulins 84
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 84
Novel analgesic treatment with prolonged effect 83
Method for the humanization of antibodies and humanized antibodies thereby obtained. 83
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 83
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 83
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 83
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 83
Method for the humanization of antibodies and humanized antibodies thereby obtained 82
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 80
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 79
Totale 10.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020648 0 0 0 0 0 0 267 42 133 56 127 23
2020/20211.736 129 8 355 10 115 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/2025968 93 34 178 172 477 14 0 0 0 0 0 0
Totale 11.418